Phase 3 Study to Evaluate the Efficacy and Safety of Peginterferon Lambda for 48 Weeks in Patients With Chronic HDV
Condition(s):Hepatitis Delta VirusLast Updated:August 25, 2023Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Hepatitis Delta VirusLast Updated:August 25, 2023Active, not recruiting
Condition(s):Progeria; HGPSLast Updated:April 15, 2021Approved for marketing
Condition(s):Hepatitis Delta VirusLast Updated:April 14, 2023Completed
Condition(s):Postbariatric HypoglycemiaLast Updated:July 18, 2022Completed
Condition(s):Chronic Delta HepatitisLast Updated:February 16, 2021Withdrawn
Condition(s):Hepatitis D, ChronicLast Updated:January 17, 2023Completed
Condition(s):Pulmonary Arterial HypertensionLast Updated:January 18, 2023Terminated
Condition(s):LymphedemaLast Updated:January 18, 2023Completed
Condition(s):Pulmonary Arterial HypertensionLast Updated:March 6, 2023Completed
Condition(s):Chronic Delta HepatitisLast Updated:June 22, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.